Credit Suisse initiated coverage on AOL (AOL) with an Underperform rating and $20 price target. Facing uphill battle, analysts said. 2009 and 2010 EPS estimates set at $2.79 and $0.79, respectively.

Autozone

(AZO) - Get Report

was upgraded from Sell to Buy, Argus Research said. $181 price target. Company has a growing presence in the commercial segment.

Bank of America/Merrill Lynch reinstated coverage on

BB&T

(BBT) - Get Report

with a Buy rating and $32 price target.

Cisco

(CSCO) - Get Report

was upgraded from Market Perform to Outperform, BMO Capital said. $30 price target. Estimates also boosted, following positive channel checks.

Expeditors

(EXPD) - Get Report

was upgraded from Neutral to Buy, UBS said. $43 price target. Earnings may be approaching an inflection point and the stock has lagged its peers.

Illinois Tool Works

(ITW) - Get Report

was upgraded from Market Perform to Outperform, Friedman, Billings Ramsey said. $58 price target. Company is guiding toward 6%-8% revenue growth. Barclays increased ITW 2009 and 2010 EPS estimates to $1.95 and $2.70, respectively. Reiterate Underweight rating and $48 price target.

CarMax (KMX) - Get Report

initiated at Bank of America/Merrill Lynch with a Buy rating and $26 price target.

Credit Suisse upgraded

Mead Johnson Nutrition

(MJN)

to Overweight from Neutral as recent decline becomes attractive entry point for investors. Price target boosted to $50 from $45. 2009 and 2010 EPS estimates set at $2.25 and $2.50, respectively.

Newfield Exploration

(NFX)

upgraded to Overweight from Equal Weight on stronger growth and free cash flow in 2010, Barclays said. Price target increased to $54 from $45. 2009 EPS estimate maintained at $5.05, 2010 raised to $4.55.

Barclays downgraded

PMC-Sierra

(PMCS)

to Equal Weight form Overweight as growth in China is slowing. Reiterate $9 dollar price target. 2009 and 2010 EPS estimates maintained at $0.48 and $0.60, respectively.

Bank of America/Merrill Lynch reinstated coverage on

PNC

(PNC) - Get Report

with a Buy rating and $62 price target.

Pharmaceutical Product Development

( PPDI) was upgraded to Buy, Jefferies said. $26 price target. New management can turn the company around.

Barclays upgraded

RadioShack

(RSH)

to Overweight from Equal weight on expectations of a strong 2010. Price target raised by $5 dollars to $25. 2009 and 2010 EPS estimate lifted to $1.66 and $1.97, respectively.

Bank of America/Merrill Lynch reinstated coverage on

Sirona Dental Systems

(SIRO)

with a Buy rating and $40 price target.

Teradyne

(TER) - Get Report

was upgraded from Neutral to Overweight, Piper Jaffray said. Company is positioned well for a cyclical upturn.

Rating on

Visa

(V) - Get Report

was boosted to Outperform, Robert Baird said. $100 price target. Expect meaningful growth acceleration.

Dentsply

(XRAY) - Get Report

XRAY reinstated at Bank of America/Merrill Lynch with a Buy rating and $40 price target.

This article was written by a staff member of TheStreet.com.